Methods and compositions for modulating and detecting wisp...

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S350000, C514S012200, C424S198100

Reexamination Certificate

active

07732567

ABSTRACT:
Methods and compositions for use in modulating the activity(s) of WISP-1 polypeptide are provided. WISP-1 antagonists include anti-WISP-1 antibodies, WISP-1 immunoadhesins and WISP-1 variants (and fusion proteins thereof) which inhibit or neutralize induction or secretion of HAS2, HA, CD44 or RHAMM by native human WISP-1 polypeptide in at least one type of mammalian cell. The invention also provides methods for in vitro, in situ, and/or in vivo diagnosis and/or treatment of mammalian cells or pathological conditions associated with native WISP-1 polypeptides.

REFERENCES:
patent: 7455834 (2006-06-01), Desnoyers et al.
patent: 7456262 (2006-06-01), Desnoyers et al.
patent: WO 99/21998 (1999-05-01), None
patent: WO 01/53486 (2001-07-01), None
patent: WO 2004/003158 (2004-01-01), None
patent: WO 2005/025603 (2005-03-01), None
Hashimoto et al., (J Exp Med. Feb. 2, 1998;187(3):289-296).
Xu et al., Genes Dev. Mar. 1, 2000;14(5):585-595.
Soon et al., (J. Biol. Chem., vol. 278, Issue 13, 11465-11470, Mar. 28, 2003).
Desnoyers et al., “WISP-1 Binds (2001) to Decorin and Biglycan”Journal of Biological Chemistry276:47599-47607.
International Search Report for PCT/US2006/014008(Aug 24, 2006).
Pennica et al., “WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors”Proc. Natl. Acad. Sci. 95:14717-14722 (Dec. 1998).
Saxena , N. et al., “Differential expression of WSIP-1 and WISP-2 genes in normal and transformed human breast cell lines”Mol. Cell. Biochem. 228:99-104 (2001).
Soon et al., “Overexpression inhibition of WISP-1 down-regulated motility and invasion of lung cancer cells through inhibition of Rac activation”J. Biol. Chemistry278(13):11465-11470 (2003).
Xie, D. et al., “Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features”Cancer Research61:8917-8923 (2001).
Xu et al., “WISP-1 is a Wnt-1- and β-catenin-responsive oncogene”Gene&Develop. 14:585-595 (2000).
Desnoyers et al., “WISP-1 Binds to Decorin and Biglycan”Journal of Biological Chemistry276:47599-47607 (2001).
Soon et al., “Overexpression of WISP-1 down-regulated motility and invasion of lung cancer cells through inhibition of Rac activation”J. Biol. Chemistry278 (13):11465-11470 (2003).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods and compositions for modulating and detecting wisp... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for modulating and detecting wisp..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for modulating and detecting wisp... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4245143

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.